Phase 2 biotech developing immunologic therapies for infectious diseases.
Industry: Health Care
First Day Return: -29.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/03/2019 |
Offer Price | $20.00 |
Price Range $20.00 - $22.00 | |
Offer Shares (mm) | 7.1 |
Deal Size ($mm) | $143 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/10/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $143 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Francisco, CA, United States |
Founded | 2016 |
Employees at IPO | 206 |
Website www.vir.bio |